John Kreft, CPA, has a strong background in finance and accounting. John has held various roles such as Chief Financial Officer at Chemistry Rx Compounding and Specialty Pharmacy, Corporate Controller at Glen-Gery and Catalyte, and Senior Corporate Accountant at Colfax Corporation. John also has experience working at KPMG US as a Senior Associate and intern. John holds a BS in Accounting and Business Law from Penn State University. John's expertise includes corporate financial planning and analysis, SEC financial reporting, and month-end close processes for corporate and global consolidation.
This person is not in any teams
Chemistry Rx Compounding and Specialty Pharmacy
Chemistry Rx is an ACHC & URAC accredited compounding and specialty pharmacy located in Folcroft, PA. Licensed in all 50 states, our mission is to provide exceptional service to our patients, providers and DTC telemedicine partners. The unique aspect about our services is our clinically-centered approach, assessing the patient's primary problem and recommending novel treatment options where compound therapies could play a significant role. Through extensive networking and research, we provide evidence based recommendations for complex cases where minimal drug therapies currently exist. Our multidisciplinary team consisting of pharmacists and nurses, have experience managing patients requiring compounded therapies for various diseases and conditions, acute and chronic, and in both adult and pediatric populations. "Overall, our pharmacists and nurses provide exceptional clinical services and ensure patient satisfaction. We are ready to take on the most challenging patient cases. Personalizing medicine, one compound at a time."